Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Marie-Ange Mouret Reynier
Based on 29 articles published since 2008
||||
Expertise Level
The expertise of Marie-Ange Mouret Reynier ranks in the
  • Top 0.44%
  • ... of 263,330 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 29 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Mouret-Reynier, Marie Ange   ·   Mouret-Reynier, M A   ·   Mouret-Reynier, Marie-Ange   ·   Mouret Reynier, Marie-Ange   ·   Mouret-Reynier, M-A   ·   Mouret-Reynier, Marie A
Work Locations
Details
Most likely:    Miscellaneous institutions in Clermont-Ferrand      
2019
  • Department of Medical Oncology, Claudius Regaud Institute, IUCT-Oncopole, Toulouse Cedex 09, France. · Department of Radiation Oncology, Curie Institute, Paris, France. · Department of Biostatistics, Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, René Gauducheau Center, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France. · Department of Radiation Oncology, François Baclesse Center, Caen, France. · Department of Surgery, Gustave Roussy Institute, Villejuif, France. · Department of Medical Oncology, Oscar Lambret Center, Lille, France. · Department of Radiation Oncology, Oscar Lambret Center, Lille, France. · Department of Medical Oncology, Bergonié Institute, Bordeaux, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Surgery, Henri Becquerel Center, Rouen, France. · Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France. · Department of Surgery, Georges-François Leclerc Center, Dijon, France. · Department of Medical Oncology, Eugène Marquis Center, Rennes, France. · Department of Surgery, René Huguenin Centre, Curie Institute, Saint-Cloud, France. · Department of Radiation Oncology, René Huguenin Centre, Curie Institute, Saint-Cloud, France. · Department of Surgery, Curie Institute, Paris, France. · Department of Medical Oncology, Antoine Lacassagne Cancer Center, Nice, France. · Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France. · Department of Medical Oncology, Jean Godinot Institute, Reims, France. · Department of Medical Oncology, Jean Perrin Center, Clermont-Ferrand, France. · Department of Medical Oncology, Paul Strauss Center, Strasbourg, France. · Biostatistics Unit, Curie Institute, PSL Research University, Paris, France. · Department of Research and Development, R&D Unicancer, Paris, France. · Department of Medical Oncology, Claudius Regaud Institute, IUCT-Oncopole, Toulouse Cedex 09, France. · Pubmed 30539492
  • Institut Curie, 35 rue Dailly, 92210, Saint-Cloud, France. · Institut Curie, 35 rue Dailly, 92210, Saint-Cloud, France. · Gustave Roussy, 94805, Villejuif, France. · Institut Claudius regaud-IUCT-Oncopole, 31059, Toulouse, France. · Centre Oscar Lambret, 59000, Lille, France. · Centre Francois Baclesse, 14000, Caen, France. · ICM, 34298, Montpellier, France. · Institut Bergonie, 33000, Bordeaux, France. · Centre Henri Becquere, 76000, Rouen, France. · Centre Georges-Francois Leclerc, 21000, Dijon, France. · Centre Eugene Marquis, 35000, Rennes, France. · Institut Paoli-Calmettes, 13009, Marseille, France. · ICL, 54519, Vandoeuvre-les-Nancy, France. · Centre Antoine Lacassagne, 06100, Nice, France. · Institut Jean Godinot, 51100, Reims, France. · Centre Paul Strauss, 67065, Strasbourg, France. · Centre Jean Perrin, 63011, Clermont-Ferrand, France. · ICO, 44805, Nantes, France. · R&D Unicancer, 75000, Paris, France. · Centre Léon Bérard, 69373, Lyon, France. · Pubmed 30357526
2018
  • Nuovo Ospedale di Prato Santo Stefano, Prato, Italy. Electronic address: · Royal Marsden Hospital, London, UK. · National Cancer Center, Gyeonggi-do, South Korea. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Universitätsklinikum Ulm, Ulm, Germany. · University of Wisconsin-Madison, Madison, WI, USA. · Centre Jean Perrin, Clermont-Ferrand, France. · Medical University of Varna, Varna, Bulgaria. · Universität Frauenklinik Innsbruck, Innsbruck, Austria. · JNSZ Megyei Hetényi Géza Kórház-Rendelőintézet, Szolnok, Hungary. · ARNAS Garibaldi, Catania, Italy. · Onkonet-Onkologie Ravensburg, Ravensburg, Germany. · Maastricht University Medical Center+, Maastricht, Netherlands. · Rainier Hematology-Oncology/Northwest Medical Specialties, Tacoma, WA, USA. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Centre Léon Bérard, Lyon, France. · Pubmed 29223745
  • Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Biostatistics, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005 Paris & Saint-Cloud, France. · Department of Medical Oncology, Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Bergonié, 229 Cours de L'Argonne, 33000 Bordeaux, France. · Department of Medical Oncology, Institut Du Cancer de Montpellier, 208 Rue des Apothicaires, 34298 Montpellier, France. · Department of Medical Oncology, Centre Jean Perrin, 58 Rue Montalembert, 63011 Clermont Ferrand, France. · Department of Medical Oncology, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud - IUCT Oncopole, 1 Avenue Irène-Joliot-Curie, 31059 Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes & Angers, 15 rue André Boquel, 49055 Angers, France. · Department of Medical Oncology, Centre Antoine Lacassagne, 33 Avenue de Valambrose, 06189 Nice, France. · Department of Medical Oncology, Centre François Baclesse, 3 Avenue du Général Harris, 14000 Caen, France. · Department of Medical Oncology, Centre Georges François Leclerc, 1 rue Professeur Marion, 21079 Dijon, France. · Medical Oncology Department, Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000 Lille, France. · Medical Oncology Department, Centre Eugéne Marquis, Avenue de la Bataille Flandres-Dunkerque, 35000 Rennes, France. · INSERM CIC1401, Institut Bergonie, Comprehensive Cancer Center, F-33000 Bordeaux, France. · Department of Medical Oncology, Centre Paul Strauss, 3 Rue de la Porte de l'Hôpital, 67000 Strasbourg, France. · Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, 1 Rue du Général Koenig, 51100 Reims, France. · Medical Oncology Department, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, 6 Avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France. · Department of Medical Oncology, Centre Henri Becquerel, Rue d'Amiens, 76000 Rouen, France. · Department of BioPathology, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Research and Development, R&D Unicancer, 101 Rue de Tolbiac, 75654 Paris, France. · Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · Pubmed 29660596
2017
  • Medical Oncology Department, Institut Curie, PSL Research University, Paris, France. · Biostatistics Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille. · Medical Oncology Department, Centre Paul Strauss, Strasbourg. · Medical Oncology Department, Gustave Roussy INSERM Unit U981, Université Paris Sud, Villejuif. · Medical Oncology Department, Institut Claudius Regaud, IUCT, Toulouse. · Medical Oncology Department, Centre François Baclesse, Caen. · Medical Oncology Department, Centre Antoine Lacassagne, Nice. · Medical Oncology Department, Institut du Cancer de Montpellier, Montpellier. · Medical Oncology Department, Centre Oscar Lambret, Lille. · Medical Oncology Department, Institut Curie, Saint Cloud. · Medical Oncology Department, Centre Léon Bérard, Lyon. · Medical Oncology Department, Centre Eugène Marquis, Rennes. · Medical Oncology Department, Institut de Cancérologie de l'Ouest, ICO Angers Nantes. · Medical Oncology Department, Institut Jean Godinot, Reims. · Medical Oncology Department, Centre Jean Perrin, Clermont Ferrand. · Medical Oncology Department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, Université Pierre et Marie Curie, Paris. · Centre Armoricain de Radiothérapie d'Imagerie médicale et d'Oncologie, Plérin. · Centre Catherine de Sienne, Nantes. · Pathology Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille. · Aix-Marseille Université, Marseille. · R&D UNICANCER, UCBG, Paris. · Department of Medical Oncology, Centre de Recherche en Cancé rologie de Marseille, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28177480
  • Department of Surgical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. · INSERM-U900 -Bioinformatics, biostatistics, epidemiology and computational systems. Biology of cancer, St Cloud, France. · Department of Pharmacogenomics, Institut Curie, Paris, France. · Institut Curie, PSL Research University, Translational Research Department, Genomic platform, Paris, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. · Department of Gynecology, Poissy-St Germain hospital, Poissy, France. · Department of Gynecology, Tenon Hospital, Paris, France. · Department of Gynecology, René Dubos Hospital, Pontoise, France. · Department of Medical Oncology, Private Hospital Clairval, Marseille, France. · Department of Surgery, Private Hospital Les Peupliers, Paris, France. · Department of Pathology, Institut Curie-Centre René Huguenin, St Cloud, France. · NanoString Technologies, Inc., Seattle, WA, United States of America. · Cedar Associates LLC, Menlo Park, CA, United States of America. · Department of Pathology, Centre Jean Perrin-UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France. · Stanford University School of Medicine, Department of Internal Medicine, Stanford, CA, United States of America. · Pubmed 29045452
  • Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; Institut de Cancérologie de l'Ouest et INSERM UMR 892 - 6299 CNRS, Nantes, France. · Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; INSERM UMR 1064 - ITUN, Nantes, France; Faculté de médecine, Université de Nantes, Nantes, France. · Institut de Cancérologie de l'Ouest et INSERM UMR 892 - 6299 CNRS, Nantes, France. · Institut du Cancer de Montpellier, Montpellier, France. · Centre Oscar Lambret, Lille, France. · Institut Curie, Paris, France. · Centre François Baclesse, Caen, France. · Centre Eugene Marquis, Rennes, France. · Institut Bergonié, Bordeaux, France. · Centre Léon Bérard, Lyon, France. · Institut Jean Godinot, Reims, France. · Centre Georges-François Leclerc, Dijon, France. · Centre Jean Perrin, Clermont-Ferrand, France. · Laboratoire de biochimie, CHU de Nantes, Nantes, France. · Faculté de médecine, Université de Nantes, Nantes, France; Laboratoire de biochimie, CHU de Nantes, Nantes, France; INSERM UMR 913, Nantes, France. · Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; INSERM UMR 1064 - ITUN, Nantes, France; Faculté de médecine, Université de Nantes, Nantes, France. Electronic address: · Pubmed 28463758
  • Department of Clinical Research, Comprehensive Anticancer Centre Jean Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Department of Oncology, Comprehensive Anticancer Centre Jean Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Department of Sport Medicine and Functional Explorations, Gabriel Montpied University Hospital, Place Henri Dunant, 63000 Clermont-Ferrand, France. · Institut de Formation des Masseurs-Kinésithérapeutes, Centre Hospitalier Lacarin, 3 Boulevard Denière, 03200 Vichy, France. · Centre Nutritionnel de Vichy, 111 Boulevard des États Unis, 03200 Vichy, France. · Department of Senology, Centre République, 99 avenue de la République, 63000 Clermont-Ferrand, France. · Department of Nutrition, Comprehensive Anticancer Centre Jean Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · University of Toulouse, Physical and Rehabilitation Medicine, 31059 Toulouse, France. · Department of Oncogenetics, Comprehensive Anticancer Centre Jean Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Pubmed 28427084
2016
  • Curie Institute, Saint-Cloud, France. · Gustave Roussy Institute, Villejuif, France. · Jean Perrin Center, Clermont Ferrand, France. · Curie Institute, Paris, France. · Hospital and University Center, Limoges, France. · Eugene Marquis Center, Rennes, France. · Curie Institute, Saint-Cloud, France. · R&D UNICANCER, UCBG, Paris, France. · Pubmed 27315583
  • Département d'Oncologie Médicale, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France; Aix-Marseille Université, Marseille, France. Electronic address: · Institut Gustave Roussy, Villejuif, France. · Département d'Oncologie Médicale, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France. · Centre Paul Strauss, Strasbourg, France. · Institut Claudius Regaud, IUCT, Toulouse, France. · Centre François Baclesse, Caen, France. · Institut Régional du Cancer de Montpellier, Montpellier, France. · Centre Oscar Lambret, Lille, France. · Centre Antoine Lacassagne, Nice, France. · Centre Eugène Marquis, Rennes, France. · Institut de Cancérologie de l'Ouest, Angers, France. · Centre Jean Perrin, Clermont Ferrand, France. · Centre Léon Bérard, Lyon, France. · Institut Curie, Saint Cloud, France. · Institut Jean Godinot, Reims, France. · Institut de Cancérologie de Lorraine, Centre Alexis Vautrin, Nancy, France. · Centre Catherine de Sienne, Nantes, France. · Centre Armoricain de Radiothérapie, d'Imagerie et d'Oncologie, Plérin, France. · Centre Hospitalier Régional Universitaire, Strasbourg, France. · Institut Bergonié, Bordeaux, France. · Département d'Oncologie Médicale, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France; Aix-Marseille Université, Marseille, France. · Institut Curie, Paris, France. · R&D UNICANCER, UCBG, Paris, France. · Institut Curie, Paris, France; Université Paris Descartes, Paris, France. · Pubmed 27032301
  • ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France. · Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · CIC 501, UMR 766, Clermont-Ferrand, France. · Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Oscar Lambret Comprehensive Cancer Centre, Lille, France. · Lucien Neuwirth Institute, Saint-Etienne, France. · Oncauvergne Regional Oncology Network, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · EA 3846, University of Auvergne, Clermont-Ferrand, France. · Inserm UMR 990, Clermont-Ferrand, France. · University of Auvergne Clermont-Ferrand, Clermont-Ferrand, France. · Pubmed 26649807
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
  • Department of Cancer Medicine, Institut Gustave Roussy, Villejuif · Department of Biostatistics, Centre Léon Bérard, Lyon. · Department of Research and Development, R&D Unicancer, Paris. · Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud. · Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes and Angers. · Department of Medical Oncology, Centre François Baclesse, Caen. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon. · Department of Medical Oncology, Centre Henri Becquerel, Rouen. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice. · Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy. · Department of Medical Oncology, Centre Eugène Marquis, Rennes. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille. · Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand. · Department of Medical Oncology, Centre Paul Strauss, Strasbourg. · Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, Reims. · Department of Medical Oncology, Centre Oscar Lambret, Lille. · Capionis, Paris, France. · Pubmed 27436849
2015
  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS 7258, Aix-Marseille Univ, Marseille. · Department of Medical Oncology, Institut Curie, Université Paris Descartes, Paris. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand. · Department of Medical Oncology, Centre Léon Bérard, Lyon. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Angers. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier. · Department of Medical Oncology, Institut Curie, Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Tenon, Paris. · Department of Medical Oncology, CHU, Tours. · Department of Medical Oncology, Polyclinique Bordeaux Nord-Aquitaine, Bordeaux. · Department of Medical Oncology, Institut Jean Godinot, Reims. · Department of Medical Oncology, CHG, Brive-la-Gaillarde. · Unicancer, Paris. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS 7258, Aix-Marseille Univ, Marseille · Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse-Oncopole,Toulouse, France. · Pubmed 25943350
  • Centre Jean Perrin, Clermont-Ferrand, France; Clinical Investigation Center (CIC), Clermont-Ferrand, France; · Centre Jean Perrin, Clermont-Ferrand, France; · Institut Jean-Godinot, Reims, France; · Centre Jean Perrin, Clermont-Ferrand, France; ERTICA EA 4677, Research Team for Individualized Cancer Treatment, and. · UMR 990 INSERM, University of Auvergne, Clermont-Ferrand, France. · Pubmed 25637380
  • Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. Electronic address: · Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Département d'oncologie médicale, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Département de chirurgie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Pubmed 26597412
2014
  • Department of Medical Oncology, Centre Georges-Francois Leclerc, Dijon, France. Electronic address: · Department of Medical Oncology, Institut Curie, Université Paris Descartes, Paris, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France. · Department of Nuclear Medicine, Hopital Tenon, Paris, France. · Department of Medical Oncology, Centre Antoine-Lacassagne, Nice, France. · Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Hospitalier Universitaire Augustin-Morvan, Brest, France. · Department of Medical Oncology et Unité INSERM U590, Centre Léon Berard, Lyon, France. · Department of Surgery, Institut Daniel Hollard, Grenoble, France. · Department of Surgery, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Clinique Hartmann, Neuilly sur Seine, France. · Department of Medical Oncology, CHU Bretonneau, Tours, France. · Department of Medical Oncology, Centre Pierre Curie, Beuvry, France. · Université François-Rabelais de Tours, CNRS, GICC UMR 7292, CHRU de Tours, Laboratory of Pharmacology-Toxicology, Tours, France. · Immunology Department, CHU Bretonneau, Tours, France. · Roche Laboratory, Boulogne Billancourt, France. · Experis IT, Nanterre, France. · Department of Pathology, Centre Georges-Francois Leclerc, Dijon, France. · Department of Nuclear Medicine, Centre Georges-Francois Leclerc, Dijon, France. · Pubmed 25456368
2015
2013
  • Department of Clinical Research, Comprehensive Anticancer Centre Jean Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Pubmed 23352440
  • Division of Clinical Research, Centre Jean Perrin, Clermont-Ferrand, France. · Pubmed 23128040
2011
  • Division of Clinical Research, Centre Jean Perrin, 58 rue Montalembert, Clermont-Ferrand F-63011, France. · Pubmed 21852136
  • Department of Surgical Oncology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, Cedex 1, France. · Pubmed 21843920
2010
  • Division of Clinical Research, Centre Jean Perrin, Clermont-Ferrand, F-63011 France. · Pubmed 21108799
Probable:    Universite Clermont Auvergne      
2016
  • ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France. · Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · CIC 501, UMR 766, Clermont-Ferrand, France. · Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Oscar Lambret Comprehensive Cancer Centre, Lille, France. · Lucien Neuwirth Institute, Saint-Etienne, France. · Oncauvergne Regional Oncology Network, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · EA 3846, University of Auvergne, Clermont-Ferrand, France. · Inserm UMR 990, Clermont-Ferrand, France. · University of Auvergne Clermont-Ferrand, Clermont-Ferrand, France. · Pubmed 26649807
2015
  • Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; Inserm UMR 990, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France; CREAT EA 7283, University of Auvergne, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France. Electronic address: · Pubmed 25900915
2014
  • ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-FerrandDepartments of Medical Oncology, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand. · Alexis Vautrin Comprehensive Cancer Centre, Nancy. · Tenon University Hospital, Paris. · Montluçon Hospital Centre, Montluçon. · Leon Berard Comprehensive Cancer Centre, Lyon. · Oscar Lambret Comprehensive Cancer Centre, Lille. · Paul Strauss Comprehensive Cancer Centre, Strasbourg. · Georges François Leclerc Comprehensive Cancer Centre, Dijon. · Departments of Medical Oncology, Clermont-Ferrand. · Jean Godinot Comprehensive Cancer Institute, Reims. · Limoges University Hospital, Limoges. · Departments of Medical Oncology, Clermont-Ferrand Oncauvergne Regional Oncology Network. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand. · Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand Inserm UMR 990, Clermont-Ferrand University of Auvergne, Clermont-Ferrand, France. · Pubmed 24827135
2017
  • ERTICA EA 4677, Université d'Auvergne, Clermont-Ferrand, France. · Pubmed 28171863
2015
  • Centre Jean Perrin, Université d'Auvergne, Clermont-Ferrand, France. · Pubmed 25472499
Possible:    Hospices Civils de Lyon      
2015
  • Department of Medical Oncology, Centre Léon Bérard, 28 rue Laennec, 69373, Lyon Cedex, France, · Pubmed 25185646
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 29 total) written by Marie-Ange Mouret Reynier about Breast Neoplasms:

  • Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis. 2019
  • Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens. 2019
  • Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial. 2018
  • Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort. 2018
  • Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab. 2017
  • Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers. 2017
  • Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer. 2017
  • Long-term improvement of breast cancer survivors' quality of life by a 2-week group physical and educational intervention: 5-year update of the 'PACThe' trial. 2017
  • A Retrospective Study on the Onset of Menopause after Chemotherapy: Analysis of Data Extracted from the Jean Perrin Comprehensive Cancer Center Database Concerning 345 Young Breast Cancer Patients Diagnosed between 1994 and 2012. 2017
  • Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609). 2016
Show List of Full Article Records
Google Searches

Learn more about Marie-Ange Mouret Reynier using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Clermont-Ferrand
Universite Clermont Auvergne
Hospices Civils de Lyon
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Clermont-Ferrand
2019
  • Department of Medical Oncology, Claudius Regaud Institute, IUCT-Oncopole, Toulouse Cedex 09, France. · Department of Radiation Oncology, Curie Institute, Paris, France. · Department of Biostatistics, Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, René Gauducheau Center, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France. · Department of Radiation Oncology, François Baclesse Center, Caen, France. · Department of Surgery, Gustave Roussy Institute, Villejuif, France. · Department of Medical Oncology, Oscar Lambret Center, Lille, France. · Department of Radiation Oncology, Oscar Lambret Center, Lille, France. · Department of Medical Oncology, Bergonié Institute, Bordeaux, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Surgery, Henri Becquerel Center, Rouen, France. · Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France. · Department of Surgery, Georges-François Leclerc Center, Dijon, France. · Department of Medical Oncology, Eugène Marquis Center, Rennes, France. · Department of Surgery, René Huguenin Centre, Curie Institute, Saint-Cloud, France. · Department of Radiation Oncology, René Huguenin Centre, Curie Institute, Saint-Cloud, France. · Department of Surgery, Curie Institute, Paris, France. · Department of Medical Oncology, Antoine Lacassagne Cancer Center, Nice, France. · Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France. · Department of Medical Oncology, Jean Godinot Institute, Reims, France. · Department of Medical Oncology, Jean Perrin Center, Clermont-Ferrand, France. · Department of Medical Oncology, Paul Strauss Center, Strasbourg, France. · Biostatistics Unit, Curie Institute, PSL Research University, Paris, France. · Department of Research and Development, R&D Unicancer, Paris, France. · Department of Medical Oncology, Claudius Regaud Institute, IUCT-Oncopole, Toulouse Cedex 09, France. · Pubmed 30539492
  • Institut Curie, 35 rue Dailly, 92210, Saint-Cloud, France. · Institut Curie, 35 rue Dailly, 92210, Saint-Cloud, France. · Gustave Roussy, 94805, Villejuif, France. · Institut Claudius regaud-IUCT-Oncopole, 31059, Toulouse, France. · Centre Oscar Lambret, 59000, Lille, France. · Centre Francois Baclesse, 14000, Caen, France. · ICM, 34298, Montpellier, France. · Institut Bergonie, 33000, Bordeaux, France. · Centre Henri Becquere, 76000, Rouen, France. · Centre Georges-Francois Leclerc, 21000, Dijon, France. · Centre Eugene Marquis, 35000, Rennes, France. · Institut Paoli-Calmettes, 13009, Marseille, France. · ICL, 54519, Vandoeuvre-les-Nancy, France. · Centre Antoine Lacassagne, 06100, Nice, France. · Institut Jean Godinot, 51100, Reims, France. · Centre Paul Strauss, 67065, Strasbourg, France. · Centre Jean Perrin, 63011, Clermont-Ferrand, France. · ICO, 44805, Nantes, France. · R&D Unicancer, 75000, Paris, France. · Centre Léon Bérard, 69373, Lyon, France. · Pubmed 30357526
2018
  • Nuovo Ospedale di Prato Santo Stefano, Prato, Italy. Electronic address: · Royal Marsden Hospital, London, UK. · National Cancer Center, Gyeonggi-do, South Korea. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Universitätsklinikum Ulm, Ulm, Germany. · University of Wisconsin-Madison, Madison, WI, USA. · Centre Jean Perrin, Clermont-Ferrand, France. · Medical University of Varna, Varna, Bulgaria. · Universität Frauenklinik Innsbruck, Innsbruck, Austria. · JNSZ Megyei Hetényi Géza Kórház-Rendelőintézet, Szolnok, Hungary. · ARNAS Garibaldi, Catania, Italy. · Onkonet-Onkologie Ravensburg, Ravensburg, Germany. · Maastricht University Medical Center+, Maastricht, Netherlands. · Rainier Hematology-Oncology/Northwest Medical Specialties, Tacoma, WA, USA. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Centre Léon Bérard, Lyon, France. · Pubmed 29223745
  • Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Biostatistics, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005 Paris & Saint-Cloud, France. · Department of Medical Oncology, Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Bergonié, 229 Cours de L'Argonne, 33000 Bordeaux, France. · Department of Medical Oncology, Institut Du Cancer de Montpellier, 208 Rue des Apothicaires, 34298 Montpellier, France. · Department of Medical Oncology, Centre Jean Perrin, 58 Rue Montalembert, 63011 Clermont Ferrand, France. · Department of Medical Oncology, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud - IUCT Oncopole, 1 Avenue Irène-Joliot-Curie, 31059 Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes & Angers, 15 rue André Boquel, 49055 Angers, France. · Department of Medical Oncology, Centre Antoine Lacassagne, 33 Avenue de Valambrose, 06189 Nice, France. · Department of Medical Oncology, Centre François Baclesse, 3 Avenue du Général Harris, 14000 Caen, France. · Department of Medical Oncology, Centre Georges François Leclerc, 1 rue Professeur Marion, 21079 Dijon, France. · Medical Oncology Department, Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000 Lille, France. · Medical Oncology Department, Centre Eugéne Marquis, Avenue de la Bataille Flandres-Dunkerque, 35000 Rennes, France. · INSERM CIC1401, Institut Bergonie, Comprehensive Cancer Center, F-33000 Bordeaux, France. · Department of Medical Oncology, Centre Paul Strauss, 3 Rue de la Porte de l'Hôpital, 67000 Strasbourg, France. · Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, 1 Rue du Général Koenig, 51100 Reims, France. · Medical Oncology Department, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, 6 Avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France. · Department of Medical Oncology, Centre Henri Becquerel, Rue d'Amiens, 76000 Rouen, France. · Department of BioPathology, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Research and Development, R&D Unicancer, 101 Rue de Tolbiac, 75654 Paris, France. · Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · Pubmed 29660596
2017
  • Medical Oncology Department, Institut Curie, PSL Research University, Paris, France. · Biostatistics Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille. · Medical Oncology Department, Centre Paul Strauss, Strasbourg. · Medical Oncology Department, Gustave Roussy INSERM Unit U981, Université Paris Sud, Villejuif. · Medical Oncology Department, Institut Claudius Regaud, IUCT, Toulouse. · Medical Oncology Department, Centre François Baclesse, Caen. · Medical Oncology Department, Centre Antoine Lacassagne, Nice. · Medical Oncology Department, Institut du Cancer de Montpellier, Montpellier. · Medical Oncology Department, Centre Oscar Lambret, Lille. · Medical Oncology Department, Institut Curie, Saint Cloud. · Medical Oncology Department, Centre Léon Bérard, Lyon. · Medical Oncology Department, Centre Eugène Marquis, Rennes. · Medical Oncology Department, Institut de Cancérologie de l'Ouest, ICO Angers Nantes. · Medical Oncology Department, Institut Jean Godinot, Reims. · Medical Oncology Department, Centre Jean Perrin, Clermont Ferrand. · Medical Oncology Department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, Université Pierre et Marie Curie, Paris. · Centre Armoricain de Radiothérapie d'Imagerie médicale et d'Oncologie, Plérin. · Centre Catherine de Sienne, Nantes. · Pathology Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille. · Aix-Marseille Université, Marseille. · R&D UNICANCER, UCBG, Paris. · Department of Medical Oncology, Centre de Recherche en Cancé rologie de Marseille, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28177480
  • Department of Surgical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. · INSERM-U900 -Bioinformatics, biostatistics, epidemiology and computational systems. Biology of cancer, St Cloud, France. · Department of Pharmacogenomics, Institut Curie, Paris, France. · Institut Curie, PSL Research University, Translational Research Department, Genomic platform, Paris, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. · Department of Gynecology, Poissy-St Germain hospital, Poissy, France. · Department of Gynecology, Tenon Hospital, Paris, France. · Department of Gynecology, René Dubos Hospital, Pontoise, France. · Department of Medical Oncology, Private Hospital Clairval, Marseille, France. · Department of Surgery, Private Hospital Les Peupliers, Paris, France. · Department of Pathology, Institut Curie-Centre René Huguenin, St Cloud, France. · NanoString Technologies, Inc., Seattle, WA, United States of America. · Cedar Associates LLC, Menlo Park, CA, United States of America. · Department of Pathology, Centre Jean Perrin-UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France. · Stanford University School of Medicine, Department of Internal Medicine, Stanford, CA, United States of America. · Pubmed 29045452
  • Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; Institut de Cancérologie de l'Ouest et INSERM UMR 892 - 6299 CNRS, Nantes, France. · Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; INSERM UMR 1064 - ITUN, Nantes, France; Faculté de médecine, Université de Nantes, Nantes, France. · Institut de Cancérologie de l'Ouest et INSERM UMR 892 - 6299 CNRS, Nantes, France. · Institut du Cancer de Montpellier, Montpellier, France. · Centre Oscar Lambret, Lille, France. · Institut Curie, Paris, France. · Centre François Baclesse, Caen, France. · Centre Eugene Marquis, Rennes, France. · Institut Bergonié, Bordeaux, France. · Centre Léon Bérard, Lyon, France. · Institut Jean Godinot, Reims, France. · Centre Georges-François Leclerc, Dijon, France. · Centre Jean Perrin, Clermont-Ferrand, France. · Laboratoire de biochimie, CHU de Nantes, Nantes, France. · Faculté de médecine, Université de Nantes, Nantes, France; Laboratoire de biochimie, CHU de Nantes, Nantes, France; INSERM UMR 913, Nantes, France. · Service de médecine et biologie du développement et de la reproduction, CHU de Nantes, Nantes, France; INSERM UMR 1064 - ITUN, Nantes, France; Faculté de médecine, Université de Nantes, Nantes, France. Electronic address: · Pubmed 28463758
  • Department of Clinical Research, Comprehensive Anticancer Centre Jean Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Department of Oncology, Comprehensive Anticancer Centre Jean Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Department of Sport Medicine and Functional Explorations, Gabriel Montpied University Hospital, Place Henri Dunant, 63000 Clermont-Ferrand, France. · Institut de Formation des Masseurs-Kinésithérapeutes, Centre Hospitalier Lacarin, 3 Boulevard Denière, 03200 Vichy, France. · Centre Nutritionnel de Vichy, 111 Boulevard des États Unis, 03200 Vichy, France. · Department of Senology, Centre République, 99 avenue de la République, 63000 Clermont-Ferrand, France. · Department of Nutrition, Comprehensive Anticancer Centre Jean Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · University of Toulouse, Physical and Rehabilitation Medicine, 31059 Toulouse, France. · Department of Oncogenetics, Comprehensive Anticancer Centre Jean Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Pubmed 28427084
2016
  • Curie Institute, Saint-Cloud, France. · Gustave Roussy Institute, Villejuif, France. · Jean Perrin Center, Clermont Ferrand, France. · Curie Institute, Paris, France. · Hospital and University Center, Limoges, France. · Eugene Marquis Center, Rennes, France. · Curie Institute, Saint-Cloud, France. · R&D UNICANCER, UCBG, Paris, France. · Pubmed 27315583
  • Département d'Oncologie Médicale, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France; Aix-Marseille Université, Marseille, France. Electronic address: · Institut Gustave Roussy, Villejuif, France. · Département d'Oncologie Médicale, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France. · Centre Paul Strauss, Strasbourg, France. · Institut Claudius Regaud, IUCT, Toulouse, France. · Centre François Baclesse, Caen, France. · Institut Régional du Cancer de Montpellier, Montpellier, France. · Centre Oscar Lambret, Lille, France. · Centre Antoine Lacassagne, Nice, France. · Centre Eugène Marquis, Rennes, France. · Institut de Cancérologie de l'Ouest, Angers, France. · Centre Jean Perrin, Clermont Ferrand, France. · Centre Léon Bérard, Lyon, France. · Institut Curie, Saint Cloud, France. · Institut Jean Godinot, Reims, France. · Institut de Cancérologie de Lorraine, Centre Alexis Vautrin, Nancy, France. · Centre Catherine de Sienne, Nantes, France. · Centre Armoricain de Radiothérapie, d'Imagerie et d'Oncologie, Plérin, France. · Centre Hospitalier Régional Universitaire, Strasbourg, France. · Institut Bergonié, Bordeaux, France. · Département d'Oncologie Médicale, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France; Aix-Marseille Université, Marseille, France. · Institut Curie, Paris, France. · R&D UNICANCER, UCBG, Paris, France. · Institut Curie, Paris, France; Université Paris Descartes, Paris, France. · Pubmed 27032301
  • ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France. · Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · CIC 501, UMR 766, Clermont-Ferrand, France. · Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Oscar Lambret Comprehensive Cancer Centre, Lille, France. · Lucien Neuwirth Institute, Saint-Etienne, France. · Oncauvergne Regional Oncology Network, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · EA 3846, University of Auvergne, Clermont-Ferrand, France. · Inserm UMR 990, Clermont-Ferrand, France. · University of Auvergne Clermont-Ferrand, Clermont-Ferrand, France. · Pubmed 26649807
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
  • Department of Cancer Medicine, Institut Gustave Roussy, Villejuif · Department of Biostatistics, Centre Léon Bérard, Lyon. · Department of Research and Development, R&D Unicancer, Paris. · Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud. · Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes and Angers. · Department of Medical Oncology, Centre François Baclesse, Caen. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon. · Department of Medical Oncology, Centre Henri Becquerel, Rouen. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice. · Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy. · Department of Medical Oncology, Centre Eugène Marquis, Rennes. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille. · Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand. · Department of Medical Oncology, Centre Paul Strauss, Strasbourg. · Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, Reims. · Department of Medical Oncology, Centre Oscar Lambret, Lille. · Capionis, Paris, France. · Pubmed 27436849
2015
  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS 7258, Aix-Marseille Univ, Marseille. · Department of Medical Oncology, Institut Curie, Université Paris Descartes, Paris. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand. · Department of Medical Oncology, Centre Léon Bérard, Lyon. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Angers. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier. · Department of Medical Oncology, Institut Curie, Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Tenon, Paris. · Department of Medical Oncology, CHU, Tours. · Department of Medical Oncology, Polyclinique Bordeaux Nord-Aquitaine, Bordeaux. · Department of Medical Oncology, Institut Jean Godinot, Reims. · Department of Medical Oncology, CHG, Brive-la-Gaillarde. · Unicancer, Paris. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS 7258, Aix-Marseille Univ, Marseille · Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse-Oncopole,Toulouse, France. · Pubmed 25943350
  • Centre Jean Perrin, Clermont-Ferrand, France; Clinical Investigation Center (CIC), Clermont-Ferrand, France; · Centre Jean Perrin, Clermont-Ferrand, France; · Institut Jean-Godinot, Reims, France; · Centre Jean Perrin, Clermont-Ferrand, France; ERTICA EA 4677, Research Team for Individualized Cancer Treatment, and. · UMR 990 INSERM, University of Auvergne, Clermont-Ferrand, France. · Pubmed 25637380
  • Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. Electronic address: · Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Département d'oncologie médicale, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Département de chirurgie, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Pubmed 26597412
2014
  • Department of Medical Oncology, Centre Georges-Francois Leclerc, Dijon, France. Electronic address: · Department of Medical Oncology, Institut Curie, Université Paris Descartes, Paris, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France. · Department of Nuclear Medicine, Hopital Tenon, Paris, France. · Department of Medical Oncology, Centre Antoine-Lacassagne, Nice, France. · Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Hospitalier Universitaire Augustin-Morvan, Brest, France. · Department of Medical Oncology et Unité INSERM U590, Centre Léon Berard, Lyon, France. · Department of Surgery, Institut Daniel Hollard, Grenoble, France. · Department of Surgery, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Clinique Hartmann, Neuilly sur Seine, France. · Department of Medical Oncology, CHU Bretonneau, Tours, France. · Department of Medical Oncology, Centre Pierre Curie, Beuvry, France. · Université François-Rabelais de Tours, CNRS, GICC UMR 7292, CHRU de Tours, Laboratory of Pharmacology-Toxicology, Tours, France. · Immunology Department, CHU Bretonneau, Tours, France. · Roche Laboratory, Boulogne Billancourt, France. · Experis IT, Nanterre, France. · Department of Pathology, Centre Georges-Francois Leclerc, Dijon, France. · Department of Nuclear Medicine, Centre Georges-Francois Leclerc, Dijon, France. · Pubmed 25456368
2015
2013
  • Department of Clinical Research, Comprehensive Anticancer Centre Jean Perrin, 58, rue Montalembert, 63011 Clermont-Ferrand, France. · Pubmed 23352440
  • Division of Clinical Research, Centre Jean Perrin, Clermont-Ferrand, France. · Pubmed 23128040
2011
  • Division of Clinical Research, Centre Jean Perrin, 58 rue Montalembert, Clermont-Ferrand F-63011, France. · Pubmed 21852136
  • Department of Surgical Oncology, Jean Perrin Comprehensive Cancer Centre, 58 rue Montalembert, 63011, Clermont-Ferrand, Cedex 1, France. · Pubmed 21843920
2010
  • Division of Clinical Research, Centre Jean Perrin, Clermont-Ferrand, F-63011 France. · Pubmed 21108799
Universite Clermont Auvergne
2016
  • ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France. · Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · CIC 501, UMR 766, Clermont-Ferrand, France. · Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Oscar Lambret Comprehensive Cancer Centre, Lille, France. · Lucien Neuwirth Institute, Saint-Etienne, France. · Oncauvergne Regional Oncology Network, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · EA 3846, University of Auvergne, Clermont-Ferrand, France. · Inserm UMR 990, Clermont-Ferrand, France. · University of Auvergne Clermont-Ferrand, Clermont-Ferrand, France. · Pubmed 26649807
2015
  • Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; Inserm UMR 990, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France; CREAT EA 7283, University of Auvergne, 63000 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France. · Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France. Electronic address: · Pubmed 25900915
2014
  • ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-FerrandDepartments of Medical Oncology, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand. · Alexis Vautrin Comprehensive Cancer Centre, Nancy. · Tenon University Hospital, Paris. · Montluçon Hospital Centre, Montluçon. · Leon Berard Comprehensive Cancer Centre, Lyon. · Oscar Lambret Comprehensive Cancer Centre, Lille. · Paul Strauss Comprehensive Cancer Centre, Strasbourg. · Georges François Leclerc Comprehensive Cancer Centre, Dijon. · Departments of Medical Oncology, Clermont-Ferrand. · Jean Godinot Comprehensive Cancer Institute, Reims. · Limoges University Hospital, Limoges. · Departments of Medical Oncology, Clermont-Ferrand Oncauvergne Regional Oncology Network. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand. · ERTICA EA 4677, University of Auvergne, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand. · Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand Inserm UMR 990, Clermont-Ferrand University of Auvergne, Clermont-Ferrand, France. · Pubmed 24827135
2017
  • ERTICA EA 4677, Université d'Auvergne, Clermont-Ferrand, France. · Pubmed 28171863
2015
  • Centre Jean Perrin, Université d'Auvergne, Clermont-Ferrand, France. · Pubmed 25472499
Hospices Civils de Lyon
2015
  • Department of Medical Oncology, Centre Léon Bérard, 28 rue Laennec, 69373, Lyon Cedex, France, · Pubmed 25185646
Yearly article counts 225572302100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.